ROVER DIAGNOSTICS

rover-diagnostics-logo

To learn more about Rover Diagnostics and its mission, please watch this presentation by Mark Fasciano, Rover's Co-Founder and CEO, for Columbia Technology Ventures: https://vimeo.com/369862917

#People #Website #More

ROVER DIAGNOSTICS

Social Links:

Founded:
2018-10-01

Website Url:
http://www.roverdx.com

Total Employee:
1+

Status:
Active

Email Addresses:
[email protected]



Current Advisors List

michael-aberman_image

Michael Aberman Board Member @ Rover Diagnostics
Board_member
2020-01-01

Current Employees Featured

samuel-sia_image

Samuel Sia
Samuel Sia Chief Science Advisor/Co-Founder @ Rover Diagnostics
Chief Science Advisor/Co-Founder

mark-fasciano_image

Mark Fasciano
Mark Fasciano CEO and Co-Founder @ Rover Diagnostics
CEO and Co-Founder
2018-10-01

Founder


mark-fasciano_image

Mark Fasciano

not_available_image

Samuel Sia

Official Site Inspections

http://www.roverdx.com

  • Host name: unalocated.63.wixsite.com
  • IP address: 185.230.63.107
  • Location: Ashburn United States
  • Latitude: 39.018
  • Longitude: -77.539
  • Metro Code: 511
  • Timezone: America/New_York
  • Postal: 20147

Loading ...

More informations about "Rover Diagnostics"

Point-of-Care RT-PCR | Women's Health | Rover Diagnostics

Rover Diagnostics is a cutting-edge medical diagnostics start-up that specializes in developing advanced PCR tests for women's health and other infectious diseases. Our primary mission is โ€ฆSee details»

ABOUT (old) - Rover Diagnostics

Based in New York City, Rover's primary mission is to bring the latest molecular diagnostics capabilities to the point-of-care at an affordable price. Our team of scientists and engineers is โ€ฆSee details»

ABOUT | Rover Diagnostics

Based in New York City, Rover's primary mission is to bring the latest molecular diagnostics capabilities to the point-of-care at an affordable price. Our multidisciplinary team is composed โ€ฆSee details»

Rover Diagnostics - Crunchbase Company Profile

Columbia U biotech spin-out developing an ultrafast point of care molecular diagnostic test for COVID-19 and other infectious diseases. View contacts for Rover Diagnostics to access new leads and connect with decision-makers.See details»

Rover Diagnostics - LinkedIn

Rover Diagnostics was founded in 2018 by Samuel Sia and Mark Fasciano in collaboration with Columbia University. Based in New York City, Roverโ€™s primary mission is to help meet the urgent global...See details»

Rover Diagnostics - PitchBook

Developer of point-of-care test kits designed for infectious diseases. The company offers tests for a broad range of infectious diseases including flu, strep, and other time-sensitive viruses, and also provides reverse transcription โ€ฆSee details»

Rover Diagnostics - VentureRadar

Website: https://roverdx.com/ Rover Diagnostics is a Columbia University spin-off developing a low-cost, simple-to-use, ultrafast point-of-care test for COVID-19. The company says its โ€ฆSee details»

Rover Diagnostics - Overview, News & Similar companies

View Rover Diagnostics (www.roverdx.com) location in New York, United States , revenue, industry and description. Find related and similar companies as well as employees by title and โ€ฆSee details»

Rover Diagnostics Developing All-Optical Rapid Point-of-Care โ€ฆ

Aug 17, 2022ย ยท NEW YORK โ€“ Startup Rover Diagnostics aims to make waves in the point-of-care space with an instrument incorporating novel optical thermal cycling and detection.See details»

ABOUT (old2) | Rover Diagnostics

Rover Diagnostics was founded in 2018 by serial tech entrepreneur Mark Fasciano and Biomedical Engineering Professor Sam Sia, in collaboration with Columbia University. Based โ€ฆSee details»

Promising COVID-19 Rapid Test Technology Enters Phase 1 of NIH ...

Highly competitive NIH RADx program selects Rover Diagnostics and biomedical engineer Sam Sia to refine and validate their low-cost, ultrafast RT PCR test.See details»

Similar companies to MindScan - VentureRadar

WordsEye allows you to literally Type a Pictureโ„ข by creating 3D graphics from text descriptions. It's a new way to turn your imagination into images and to create memes, greeting cards, or โ€ฆSee details»

RoverDx LightSpeed Womenโ€™s Health Testing in Point of Care Settin

RoverDx LightSpeed Womenโ€™s Health Testing in Point of Care Settings Sep 2024. Martha Najib. Chief Strategy & Commercial Officer. RoverDx. Vaginitis is the leading reason for OB/GYN โ€ฆSee details»

Promising COVID-19 rapid test technology ente | EurekAlert!

Highly competitive NIH RADx program selects Rover Diagnostics and biomedical engineer Sam Sia to refine and validate their low-cost, ultrafast RT PCR test.See details»

New COVID-19 Rapid-test Technology Performs PCR Faster than โ€ฆ

Researchers at Columbia Engineering and Rover Diagnostics announced today that they have built an RT-PCR platform that gives results in 23 minutes that match the longer laboratory โ€ฆSee details»

Point-of-Care RT-PCR | Rover Diagnostics

Rover Diagnostics is a cutting-edge medical diagnostics start-up that specializes in developing advanced PCR tests for COVID-19 and other infectious diseases. Our primary mission is to โ€ฆSee details»

Log in to your Okta org

If you donโ€™t have an Okta organization or credentials, use the Okta Digital Experience Account to get access to Learning Portal, Help Center, Certification, Okta.com, and much more. Learn โ€ฆSee details»

CONTACT - Rover Diagnostics

Contact us! If you would like to learn more, please submit the following form and someone will be in touch shortly. RoverDx is located at the Lasker Biomedical Research Building at Columbia โ€ฆSee details»

What is a matrix organization and how does it work? - Asana

Feb 22, 2024ย ยท What is a matrix organization and how does it work? A matrix organization is a company structure where teams report to multiple leaders. The matrix design keeps open โ€ฆSee details»

TECHNOLOGY - Rover Diagnostics

Rover Diagnostics is developing a low-cost, simple-to-use, ultrafast point-of-care test for COVID-19 and other infectious diseases. Widely used since the 1980s in both clinical and research โ€ฆSee details»